Ma W - Search Results

1

Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.

Sheikholeslami MR, Ma W, Uyeji J, Tornyos K, Cone L, Mamus S, Albitar M. Sheikholeslami MR, et al. Among authors: ma w. Br J Haematol. 2007 Nov;139(3):507-9. doi: 10.1111/j.1365-2141.2007.06805.x. Epub 2007 Sep 14. Br J Haematol. 2007. PMID: 17868045 Free article. No abstract available.

2

Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.

Ma W, Kantarjian H, O'Brien S, Jilani I, Zhang X, Estrov Z, Ferrajoli A, Keating M, Giles F, Albitar M. Ma W, et al. Cancer. 2008 Mar 15;112(6):1306-12. doi: 10.1002/cncr.23301. Cancer. 2008. PMID: 18224667 Free article.

3

Higher detection rate of JAK2 mutation using plasma.

Ma W, Kantarjian H, Zhang X, Sun W, Buller AM, Jilani I, Schwartz JG, Giles F, Albitar M. Ma W, et al. Blood. 2008 Apr 1;111(7):3906-7. doi: 10.1182/blood-2008-02-139188. Blood. 2008. PMID: 18362222 Free article. No abstract available.

4

Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

Ma W, Kantarjian H, Zhang X, Yeh CH, Zhang ZJ, Verstovsek S, Albitar M. Ma W, et al. J Mol Diagn. 2009 Jan;11(1):49-53. doi: 10.2353/jmoldx.2009.080114. Epub 2008 Dec 12. J Mol Diagn. 2009. PMID: 19074595 Free PMC article.

5

B-cell clones as early markers for chronic lymphocytic leukemia.

Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE. Landgren O, et al. Among authors: ma w. N Engl J Med. 2009 Feb 12;360(7):659-67. doi: 10.1056/NEJMoa0806122. N Engl J Med. 2009. PMID: 19213679 Free PMC article.

6

K-ras mutations and cetuximab in colorectal cancer.

Albitar M, Yeh C, Ma W. Albitar M, et al. Among authors: ma w. N Engl J Med. 2009 Feb 19;360(8):834; author reply 835-6. N Engl J Med. 2009. PMID: 19238675 No abstract available.

7

Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.

Ma W, Kantarjian H, Zhang X, Jilani I, Sheikholeslami MR, Donahue AC, Ravandi F, Estey E, O'Brien S, Keating M, Giles FJ, Albitar M. Ma W, et al. Cancer Biomark. 2009;5(1):51-8. doi: 10.3233/CBM-2009-0583. Cancer Biomark. 2009. PMID: 19242062 Clinical Trial.

8

BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.

Ma W, Kantarjian H, Yeh CH, Zhang ZJ, Cortes J, Albitar M. Ma W, et al. Acta Haematol. 2009;121(1):27-31. doi: 10.1159/000210060. Epub 2009 Mar 31. Acta Haematol. 2009. PMID: 19332983 Free PMC article. Review. No abstract available.

9

Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations.

Lee TS, Ma W, Zhang X, Kantarjian H, Albitar M. Lee TS, et al. Among authors: ma w. BMC Struct Biol. 2009 Sep 10;9:58. doi: 10.1186/1472-6807-9-58. BMC Struct Biol. 2009. PMID: 19744331 Free PMC article.

10

Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.

Bruey JM, Kantarjian H, Ma W, Estrov Z, Yeh C, Donahue A, Sanders H, O'Brien S, Keating M, Albitar M. Bruey JM, et al. Among authors: ma w. Leuk Res. 2010 Oct;34(10):1320-4. doi: 10.1016/j.leukres.2010.03.010. Epub 2010 Apr 1. Leuk Res. 2010. PMID: 20362333 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,757 results

Search Page